Faculty profile

Loretta Fiorillo

Back to faculty

Limited-Term Clinical ProfessorPost Grad Medical EducationUniversity of Alberta

Loretta Fiorillo

Limited-Term Clinical Professor

Post Grad Medical Education

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
13 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

148

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes: A Randomized Controlled Trial.
Journal of cutaneous medicine and surgery · 2026
Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.
Dermatology and therapy · 2026
Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial.
Journal of the American Academy of Dermatology · 2026

All 34 publications

34 publications.

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes: A Randomized Controlled Trial.

Leung MSY, Li K, Zheng D, Bernier C, Kharel A, Dienes S, Abdi P, Yu A, Bai JQA, Maruschak-Love S, Turk T, Bosonea AM, Chow EY, Fiorillo L, Sanchez-Espino LF, Ting P, Gniadecki R, Dytoc M

Journal of cutaneous medicine and surgery2026Open Access

DOI: 10.1177/12034754261480661 PMID: 42725690

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.

Langley RG, Arkin L, Fiorillo L, Eichenfield LF, Lebwohl M, Strober B, Sticherling M, Swanson L, Kokolakis G, Chaudhari S, Deignan C, Zhang Z, Paller AS

Dermatology and therapy2026

DOI: 10.1007/s13555-026-01714-0 PMID: 42133282

Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial.

Langley RG, Arkin L, Fiorillo L, Eichenfield LF, Lebwohl M, Strober B, Sticherling M, Swanson L, Kokolakis G, Chaudhari S, Deignan C, Zhang Z, Paller AS

Journal of the American Academy of Dermatology2026

DOI: 10.1016/j.jaad.2026.01.072 PMID: 41643746

Pyoderma gangrenosum as a rare manifestation of myelodysplastic syndrome in a pediatric patient: A case report.

Yu AC, Chan AR, Fiorillo L

SAGE open medical case reports2026Senior author

DOI: 10.1177/2050313x251411531 PMID: 42542782

Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial

Amy S. Paller, Loretta Fiorillo, Emily Becker, Susana Armesto, Apostolos Kontzias, Rajneet K. Oberoi, Wendy Zhang, Hamid R. Amouzadeh, Zuoshun Zhang, Lisa M. Arkin

British Journal of Dermatology20253 citationsOpen Access

DOI: 10.1093/bjd/ljaf305 PMID: 40737559

Asymptomatic Crohn's disease presenting as perianal masses in a child: A case report and literature review.

Rahman S, Fiorillo L

SAGE open medical case reports2025Senior author

DOI: 10.1177/2050313x251320194 PMID: 40297639

Progressive Soft Tissue Swelling in a Pediatric Patient Leading to the Diagnosis of Fibrodysplasia Ossificans Progressiva: A Case Report.

Yilmaz O, Fiorillo L

Pediatric dermatology2025Senior author

DOI: 10.1111/pde.15962 PMID: 40437772

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial

Loretta Fiorillo, Emily Becker, R. de Lucas, Anna Belloni Fortina, Susana Armesto, Boni Elizabeth Elewski, Peter Maes, Rajneet K. Oberoi, Maria M. Paris, Wendy Zhang, Zuoshun Zhang, Lisa M. Arkin

Journal of the American Academy of Dermatology202431 citationsFirst authorOpen Access

DOI: 10.1016/j.jaad.2023.11.068 PMID: 38266683

Two cases of childhood linear immunoglobulin A bullous dermatosis following multivisceral transplant: A case report.

Yu AC, Chan AR, Wong K, Walker K, Fiorillo L

SAGE open medical case reports20242 citationsSenior authorOpen Access

DOI: 10.1177/2050313x241304956 PMID: 39734793

Arteriovenous malformation with hair collar sign.

Hollman D, Alzahrani F, Fiorillo L, Thompson A, Mahmood MN

Pediatric dermatology2024

DOI: 10.1111/pde.15482 PMID: 38085129

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Loretta Fiorillo

Research

Latest papers

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes: A Randomized Controlled Trial.

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.

Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial.

Pyoderma gangrenosum as a rare manifestation of myelodysplastic syndrome in a pediatric patient: A case report.

Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial

Asymptomatic Crohn's disease presenting as perianal masses in a child: A case report and literature review.

Progressive Soft Tissue Swelling in a Pediatric Patient Leading to the Diagnosis of Fibrodysplasia Ossificans Progressiva: A Case Report.

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial

Two cases of childhood linear immunoglobulin A bullous dermatosis following multivisceral transplant: A case report.

Arteriovenous malformation with hair collar sign.

Frequent collaborators

Michèle Ramien

Weiguo Zhang

Perla Lansang

Elena Pope

Laura Soong

Joan Robinson

Karen Naert

Jensen Yeung

Marissa Joseph

Dale Lien

Kirsten Walker

John Mullen

Neel Malhotra

Ivan Litvinov

Robert Gniadecki

Loretta Fiorillo

Research

Latest papers

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes: A Randomized Controlled Trial.

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase&#xa0;3 Trial.

Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial.

Pyoderma gangrenosum as a rare manifestation of myelodysplastic syndrome in a pediatric patient: A case report.

Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial

Asymptomatic Crohn's disease presenting as perianal masses in a child: A case report and literature review.

Progressive Soft Tissue Swelling in a Pediatric Patient Leading to the Diagnosis of Fibrodysplasia Ossificans Progressiva: A Case Report.

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial

Two cases of childhood linear immunoglobulin A bullous dermatosis following multivisceral transplant: A case report.

Arteriovenous malformation with hair collar sign.

Frequent collaborators

Michèle Ramien

Weiguo Zhang

Perla Lansang

Elena Pope

Laura Soong

Joan Robinson

Karen Naert

Jensen Yeung

Marissa Joseph

Dale Lien

Kirsten Walker

John Mullen

Neel Malhotra

Ivan Litvinov

Robert Gniadecki

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.